C17orf72 Activators

Chemical activators of C17orf72 include a variety of compounds that influence different intracellular signaling pathways leading to its activation. Dibutyryl cyclic AMP, a cAMP analog, permeates cell membranes and activates protein kinase A (PKA). Once active, PKA can phosphorylate and thereby activate C17orf72. Similarly, Forskolin elevates intracellular cAMP by directly stimulating adenylyl cyclase, subsequently activating PKA, which in turn can target C17orf72. Phorbol 12-myristate 13-acetate (PMA) functions by activating protein kinase C (PKC), which is known for phosphorylating various cellular substrates, including proteins like C17orf72. Another activator, Ionomycin, raises intracellular calcium levels, which can activate calmodulin-dependent protein kinases capable of phosphorylating and activating C17orf72.

The activation of C17orf72 can also be influenced by growth factors such as Epidermal Growth Factor (EGF), which upon binding to its receptor, triggers the MAPK/ERK pathway, often resulting in phosphorylation and activation of various proteins, C17orf72 included. Oxidative stress induced by Hydrogen peroxide can lead to a decrease in the activity of phosphatases, maintaining proteins like C17orf72 in a phosphorylated and active state. In the milieu of nitric oxide donors, S-Nitroso-N-acetylpenicillamine (SNAP) leads to the activation of protein kinase G (PKG), which can phosphorylate and activate C17orf72. Lithium chloride, through the inhibition of GSK-3β, may allow for the activation of C17orf72 by preventing inhibitory phosphorylation. Similarly, BAY 11-7082, by inhibiting NF-κB signaling, may create a cellular environment that favors the activation of C17orf72. The application of stress-activated kinase inducers such as Anisomycin leads to the activation of SAPKs, which can activate C17orf72 through phosphorylation. Lastly, the use of phosphatase inhibitors like Okadaic Acid and Calyculin A results in increased phosphorylation levels of cellular proteins, including C17orf72, due to the decreased activity of protein phosphatases 1 and 2A, leading to the activation of C17orf72.